Resources > Blog

post

Three Fundamental Challenges Contributing to Prolonged Industry-sponsored Clinical Trial Budget Negotiations

With clinical trial budget negotiation being one of the biggest contributors to lost time during study start-up, a transformation towards efficiency and clarity is essential.
post

7 Reasons Why Community-Based Sites are Key to The Future of Research

Community sites bring powerful access to more patients and more diverse populations. They have many unique advantages that make them key to the future of research. We believe in the power of community sites for these 7 reasons:
post

4 ways to save time and simplify your next trial search with Inato

Whether you’re focused on finding a specific type of clinical trial for your patients or working to line up more trials for your research center, you’ve probably spent some time in front of your computer, combing through the online depths of the highly gated clinical research universe.
post

Sustainability in Trials: Saving Patients and the Planet

Despite an overarching goal to save lives through medicine, the clinical trial industry leaves behind a crushing carbon footprint.
post

A Gap in Research: How a Scarcity of Data is Affecting LGBTQ+ Healthcare Access

Striving for diversity across trials means striving for the inclusion of members of the LGBTQ+ community as well and recognizing gaps in research and representation.
post

Site Spotlight: One Michigan based site’s efforts to increase trial access for Black Americans.

Founded on a commitment to provide patients in Detroit, Michigan with high quality research opportunities, Great Lakes Research Institute brings trials to a primarily Black American patient population.
post

Site Insights: The global efforts to uncover a cure for Lupus

A lupus diagnosis means a lifelong battle with inflammation, be it in the skin, joints, blood cells, brain, kidney, or heart and, at present, there is no cure to the chronic illness. Both the sites and sponsors Inato works with are diligently striving to develop effective treatments for lupus.
post

Site Insights: Joining the Fight Against Alzheimer's

Across the globe, Alzheimer’s Dementia is steadily increasing to epidemic proportions with nearly 55 million adults living with Alzheimer’s and other dementias in the world today. As Inato has worked with sponsors to publish Ahlzeimer’s studies onto our platform, sites across our network have stepped up to join in the fight against this disease.
post

Women's History Month Spotlight: Leaders in the Industry

Throughout Women’s History Month, we reached out to leaders in the clinical trial industry to hear their perspectives on women’s health and leadership. Each woman featured displayed compassion and commitment to striving for true gender equality within the industry.
post

Breaking the Cycle: Calling for Gender Equality in the Tech Industry

Despite making up 47% of the U.S. workforce, women only account for 28% of tech leadership positions. It’s a steady cycle of underrepresentation feeding antiquated tech company cultures and preventing women from entering and climbing in the industry.
post

A Gap in Research: The Ongoing Issue of Gender Disparity in Clinical Trials

As the medical field has come to better understand gender disparities, the startling realization has emerged that many medications on the market today were deemed effective without being thoroughly researched on women.
post

A Closer Look at SCOPE 2022

Inato’s Liz Beatty spoke alongside Sanofi’s Kim Hawkins to present how their teams worked together to accelerate and diversify trials.